Trial Profile
A registry based study investigating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for the prevention of pertussis among adolescents
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Aug 2023
Price :
$35
*
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Pertussis
- Focus Therapeutic Use
- 30 Dec 2015 New trial record